Sanofi buys Ablynx for $4.8 billion in biotech M&A boom

French drugmaker Sanofi has agreed to buy Belgian biotech company Ablynx for $4.8 billion, beating Novo Nordisk and marking its second big deal this month after buying Bioverativ."Sanofi buys Ablynx for $4.8 billion in biotech M&A boom" via FOX BIZ http://ift.tt/2GstTDM